TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 23890168

Group type: EXPERIMENTAL
Intervention: Transrectus sheath preperitoneal procedure (TREPP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Transinguinal preperitoneal procedure (control)
Number of subjects: 0
Study: 21718184

Group type: EXPERIMENTAL
Intervention: Phosphatidylcholine/deoxycholic acid
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Conjonctyl®
Number of subjects: 75
Study: 17610527

Group type: EXPERIMENTAL
Intervention: PC-SOD 20 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: PC-SOD 40 mg
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: PC-SOD 80 mg
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 16927761

Group type: EXPERIMENTAL
Intervention: Air endo‐tamponade (complete fluid‐air exchange)
Number of subjects: 40

Group type: COMPARATOR
Intervention: BSS Plus (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Air endo‐tamponade
Number of subjects: 40
Study: 12586451

Group type: EXPERIMENTAL
Intervention: Electroconvulsive therapy (ECT)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Overall response rate
Number of subjects: 40
Study: 11115156

Group type: EXPERIMENTAL
Intervention: Alitretinoin gel (0.05% or 0.1% applied twice daily for the first 2 weeks and up to 4 times daily thereafter)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Untreated control lesions
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Alitretinoin gel
Number of subjects: 115
Study: 9154995

Group type: EXPERIMENTAL
Intervention: Angiotensin-II (A-II) at pressor doses (8.44 ng/kg/min)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Angiotensin-II (A-II) at subpressor doses (0.62 ng/kg/min)
Number of subjects: 8
Study: 8425695

Group type: EXPERIMENTAL
Intervention: Cyclosporin A (CyA), 3 mg.kg‐1.day‐1
Number of subjects: 349

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 349
Study: 3322166

Group type: EXPERIMENTAL
Intervention: 300‐kcal mixed diet with exercise training
Number of subjects: 40

Group type: COMPARATOR
Intervention: 300‐kcal mixed diet alone
Number of subjects: 40
Study: 31710250

Group type: EXPERIMENTAL
Intervention: CARE-call system
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group (standard treatment)
Number of subjects: 100
Study: 30243294

Group type: COMPARATOR
Intervention: Sevoflurane-based inhalational anesthesia (SEV group)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Propofol/remifentanil-based total intravenous anesthesia (TIVA group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Comparison of two groups
Number of subjects: 80
Study: 26433523

Group type: EXPERIMENTAL
Intervention: TAVR
Number of subjects: 226

Group type: COMPARATOR
Intervention: SAVR
Number of subjects: 226
Study: 24445147

Group type: EXPERIMENTAL
Intervention: Capecitabine (625 mg/m² twice daily orally) + Streptozocin (1.0 g/m² intravenously on day 1)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Capecitabine (625 mg/m² twice daily orally) + Streptozocin (1.0 g/m² intravenously on day 1) + Cisplatin (70 mg/m² intravenously on day 1)
Number of subjects: 86
Study: 22991109

Group type: EXPERIMENTAL
Intervention: Group educational activities using problematization methodology
Number of subjects: 62

Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 62
Study: 20691266

Group type: EXPERIMENTAL
Intervention: PfCS102 (30 μg, twice)
Number of subjects: 16

Group type: COMPARATOR
Intervention: ISA 720 (control)
Number of subjects: 16
Study: 17899104

Group type: EXPERIMENTAL
Intervention: Prolonged catheter drainage with negative pressure
Number of subjects: 40

Group type: COMPARATOR
Intervention: Single-session alcohol sclerotherapy
Number of subjects: 40
Study: 16873668

Group type: EXPERIMENTAL
Intervention: Pamidronate plus thalidomide (arm C)
Number of subjects: 597

Group type: EXPERIMENTAL
Intervention: Pamidronate (arm B)
Number of subjects: 597

Group type: COMPARATOR
Intervention: No maintenance (arm A)
Number of subjects: 597
Study: 12600851

Group type: COMPARATOR
Intervention: High-carbohydrate, high-GI diet
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: High-carbohydrate, low-GI diet
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Low-carbohydrate, high-MUFA diet
Number of subjects: 34
Study: 11286039

Group type: EXPERIMENTAL
Intervention: 50 mg oral sumatriptan
Number of subjects: 233

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 233
Study: 8972000

Group type: EXPERIMENTAL
Intervention: Sak42D (15 mg each, double bolus, 30 min apart)
Number of subjects: 24

Group type: COMPARATOR
Intervention: rt‐PA (accelerated weight-adjusted, maximum of 100 mg over 90 min)
Number of subjects: 24
Study: 1600703

Group type: EXPERIMENTAL
Intervention: Intranasal insulin (0.3 U kg‐1, 0.6 U kg‐1, 0.8 U kg‐1)
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Intranasal insulin
Number of subjects: 11

Group type: COMPARATOR
Intervention: Intravenous insulin (4 U)
Number of subjects: 11

Group type: COMPARATOR
Intervention: Subcutaneous insulin (6 U)
Number of subjects: 11
Study: 2861219

Group type: EXPERIMENTAL
Intervention: 0.05 mg procaterol
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: 0.10 mg procaterol
Number of subjects: 45

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study: 30346675

Group type: EXPERIMENTAL
Intervention: GC‐Europe (Aadva)
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: True‐Definition‐TD
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Trios
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional impressions (Control)
Number of subjects: 30
Study: 27437937

Group type: EXPERIMENTAL
Intervention: Food insecurity prevalence
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Age
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Less than high school completion
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Needing health care but not receiving it
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Subjective mental health
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Spent over $500 for drugs and alcohol in the past month
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: HIV/AIDS
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Heart disease
Number of subjects: 421

Group type: EXPERIMENTAL
Intervention: Going to a drop‐in centre, community meal centre or program/food bank
Number of subjects: 421
Study: 23515755

Group type: EXPERIMENTAL
Intervention: Lichtenstein hernioplasty using acellular tissue matrix (ACTM) grafts
Number of subjects: 100

Group type: COMPARATOR
Intervention: Traditional high ligation of the hernia sac (control group)
Number of subjects: 100
Study: 24391822

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg/day
Number of subjects: 114

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 114
Study: 20736432

Group type: EXPERIMENTAL
Intervention: ETTc pressure measured and adjusted
Number of subjects: 509

Group type: COMPARATOR
Intervention: Control group without measuring ETTc pressure
Number of subjects: 509
Study: 19008171

Group type: EXPERIMENTAL
Intervention: Oxy-Gen lite technology (pulsatile oxygen delivery)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Standard continuous oxygen therapy (maximal flow rate of 2 L/min)
Number of subjects: 32
Study: 15705022

Group type: EXPERIMENTAL
Intervention: Cetylated fatty acid (CFA) topical cream applied twice per day for 30 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo topical cream
Number of subjects: 40

Group type: COMPARATOR
Intervention: CFA and Placebo (subgroup analysis)
Number of subjects: 40
Study: 12573937

Group type: EXPERIMENTAL
Intervention: Methylphenidate (MPH) and Adderall
Number of subjects: 21

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study: 10472228

Group type: EXPERIMENTAL
Intervention: Ropivacaine (285 mg)
Number of subjects: 80
Study: 9096850

Group type: EXPERIMENTAL
Intervention: Selenium (Se) supplementation as sodium selenite
Number of subjects: 10
Study: 1867580

Group type: EXPERIMENTAL
Intervention: Immediate oral intake of fluids (water, tea or coffee with sugar) without limitation of quantity
Number of subjects: 51

Group type: COMPARATOR
Intervention: Fasting at least until 24 hours after the end of the operation
Number of subjects: 51
Study: 7052613

Group type: EXPERIMENTAL
Intervention: Transfer factor (TF) administered subcutaneously equivalent to 5 x 10^8 lymphocytes, given twice at one week intervals and then every four weeks thereafter.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transfer factor (TF) group
Number of subjects: 0
Study: 30862118

Group type: EXPERIMENTAL
Intervention: Mentor-led text-messaging intervention
Number of subjects: 411

Group type: COMPARATOR
Intervention: Delayed control (no text messages)
Number of subjects: 411
Study: 29136630

Group type: EXPERIMENTAL
Intervention: Catcher Tagged group (TAG)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Net forceps group (NET)
Number of subjects: 64
Study: 27222459

Group type: EXPERIMENTAL
Intervention: Manual-guided self-learning programme (bibliotherapy) in addition to usual care
Number of subjects: 116
Study: 25200559

Group type: EXPERIMENTAL
Intervention: Roux-en-Y gastric bypass (RYGB) plus optimised clinical treatment (OCT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Optimised clinical treatment (OCT) alone
Number of subjects: 60
Study: 22362922

Group type: EXPERIMENTAL
Intervention: State anxiety induction task
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control task
Number of subjects: 110
Study: 19647342

Group type: EXPERIMENTAL
Intervention: Paracetamol (1 g)
Number of subjects: 146

Group type: EXPERIMENTAL
Intervention: Morphine (0.1 mg/kg)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Placebo (normal saline solution)
Number of subjects: 146
Study: 17725934

Group type: EXPERIMENTAL
Intervention: 1 mg of lorazepam (n=47)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo (n=48)
Number of subjects: 95
Study: 15185267

Group type: EXPERIMENTAL
Intervention: Cognitive-behavior therapy for bulimia nervosa
Number of subjects: 80
Study: 12186124

Group type: EXPERIMENTAL
Intervention: Simvastatin
Number of subjects: 48

Group type: COMPARATOR
Intervention: Pravastatin
Number of subjects: 48
Study: 9524424

Group type: EXPERIMENTAL
Intervention: Inactive phase of SLE pregnancies
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Hematological autoimmune presentations (APA)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Any kind of hemocytopenias without APA
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 75
Study: 8595188

Group type: EXPERIMENTAL
Intervention: Right unilateral brain-damaged patients with neglect
Number of subjects: 4

Group type: COMPARATOR
Intervention: Left and right patients without neglect or hemianopia
Number of subjects: 4

Group type: COMPARATOR
Intervention: Patients with left or right retrogeniculate lesions and lateral homonymous hemianopia
Number of subjects: 4
Study: 2565346

Group type: EXPERIMENTAL
Intervention: L-dopa (small repeated doses)
Number of subjects: 35

Group type: EXPERIMENTAL
Intervention: L-dopa (small repeated doses) + haloperidol 15 mg
Number of subjects: 35

Group type: COMPARATOR
Intervention: Placebo control group
Number of subjects: 35
Study: 100866

Group type: EXPERIMENTAL
Intervention: i.v. TRH infusion (0.66 mg/hour) for 3 hours
Number of subjects: 6
Study: 30993840

Group type: EXPERIMENTAL
Intervention: Breastfeeding
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Heel warming
Number of subjects: 150

Group type: COMPARATOR
Intervention: Control
Number of subjects: 150
Study: 28085236

Group type: EXPERIMENTAL
Intervention: Budesonide 3 mg
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 26407587

Group type: EXPERIMENTAL
Intervention: Hypoglycemic night (PG target of 2.7-2.8 mmol/L maintained for 15 min)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Normoglycemic night (PG maintained at 5.0-7.0 mmol/L)
Number of subjects: 26
Study: 23704674

Group type: EXPERIMENTAL
Intervention: Metformin plus rosiglitazone
Number of subjects: 699

Group type: COMPARATOR
Intervention: Metformin alone
Number of subjects: 699

Group type: COMPARATOR
Intervention: Metformin plus lifestyle
Number of subjects: 699

Group type: EXPERIMENTAL
Intervention: All treatments (irrespective of group)
Number of subjects: 699
Study: 21802658

Group type: EXPERIMENTAL
Intervention: remifentanil (MOR agonist)
Number of subjects: 22

Group type: COMPARATOR
Intervention: healthy control subjects
Number of subjects: 22
Study: 19101253

Group type: EXPERIMENTAL
Intervention: SP-led feedback
Number of subjects: 32

Group type: COMPARATOR
Intervention: No feedback (control)
Number of subjects: 32
Study: 17615281

Group type: EXPERIMENTAL
Intervention: Acetazolamide (250 mg three times a day for 24 hours)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 15131431

Group type: EXPERIMENTAL
Intervention: Mini-intervention (A)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Mini-intervention plus worksite visit (B)
Number of subjects: 164

Group type: COMPARATOR
Intervention: Usual care (C)
Number of subjects: 164

Group type: EXPERIMENTAL
Intervention: Mini-intervention (A) and Mini-intervention plus worksite visit (B)
Number of subjects: 164
Study: 11936460

Group type: EXPERIMENTAL
Intervention: Inland territory (goiter prevalence)
Number of subjects: 13984

Group type: EXPERIMENTAL
Intervention: Sea level (goiter prevalence)
Number of subjects: 13984

Group type: EXPERIMENTAL
Intervention: Neonatal TSH levels (inland territory)
Number of subjects: 13984

Group type: EXPERIMENTAL
Intervention: Neonatal TSH levels (sea level)
Number of subjects: 13984

Group type: EXPERIMENTAL
Intervention: Urinary iodine excretion (inland territory)
Number of subjects: 13984

Group type: EXPERIMENTAL
Intervention: Urinary iodine excretion (sea level)
Number of subjects: 13984

Group type: EXPERIMENTAL
Intervention: Median urinary iodine excretion (inland villages)
Number of subjects: 13984

Group type: EXPERIMENTAL
Intervention: Median urinary iodine excretion (Crotone)
Number of subjects: 13984

Group type: EXPERIMENTAL
Intervention: Median urinary iodine excretion (Reggio Calabria)
Number of subjects: 13984
Study: 9649661

Group type: EXPERIMENTAL
Intervention: 1alpha,25-dihydroxyvitamin D3 (VD3)
Number of subjects: 0
Study: 8021472

Group type: EXPERIMENTAL
Intervention: 6 g purified fish oil once a day for 6 months
Number of subjects: 350

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 350
Study: 2511253

Group type: EXPERIMENTAL
Intervention: Urine samples from HIV-1 seropositive individuals
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Peripheral blood mononuclear cell samples
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Urine samples for HIV-1 p24 antigen by ELISA
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Peripheral blood samples for serum HIV-1 p24 antigen
Number of subjects: 48
Study: 28749254

Group type: EXPERIMENTAL
Intervention: Moderate training (60% MAP, 5 min blocks with 1 min recovery)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: High training (100% MAP, 2 min with 3 min recovery)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Mixed training (two moderate and two high-intensity sessions weekly)
Number of subjects: 34
Study: 27609854

Group type: EXPERIMENTAL
Intervention: INSD ketamine (1 mg/kg)
Number of subjects: 80

Group type: COMPARATOR
Intervention: IN fentanyl (1.5 μg/kg)
Number of subjects: 80
Study: 25917674

Group type: EXPERIMENTAL
Intervention: Rotavirus vaccine (Rotarix)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Sucrose solution (Tootsweet)
Number of subjects: 120
Study: 23064291

Group type: EXPERIMENTAL
Intervention: Intensive multifactorial treatment (IT)
Number of subjects: 1533

Group type: COMPARATOR
Intervention: Routine care (RC)
Number of subjects: 1533
Study: 20601159

Group type: EXPERIMENTAL
Intervention: Newspaper advertisements
Number of subjects: 197

Group type: EXPERIMENTAL
Intervention: Posters
Number of subjects: 197

Group type: COMPARATOR
Intervention: Family physician recruiters
Number of subjects: 197

Group type: COMPARATOR
Intervention: Family physician referrals
Number of subjects: 197

Group type: COMPARATOR
Intervention: Community presentations
Number of subjects: 197

Group type: COMPARATOR
Intervention: Community events
Number of subjects: 197

Group type: COMPARATOR
Intervention: Newsletters
Number of subjects: 197

Group type: COMPARATOR
Intervention: Direct mailings
Number of subjects: 197

Group type: COMPARATOR
Intervention: Word of mouth
Number of subjects: 197
Study: 18379218

Group type: EXPERIMENTAL
Intervention: HiMF training (HiMFT)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: LoMF training (LoMFT)
Number of subjects: 49

Group type: COMPARATOR
Intervention: HiMF control (HiMFC)
Number of subjects: 49

Group type: COMPARATOR
Intervention: LoMF control (LoMFC)
Number of subjects: 49
Study: 15722811

Group type: EXPERIMENTAL
Intervention: Chronic whiplash‐associated disorders
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Chronic idiopathic neck pain
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group (pain-free volunteers)
Number of subjects: 69
Study: 12917125

Group type: EXPERIMENTAL
Intervention: 3D fractal analysis of CBF SPECT images in AD patients
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: 3D fractal analysis of CBF SPECT images in VaD patients
Number of subjects: 74

Group type: COMPARATOR
Intervention: Control group (age-matched subjects)
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Comparison of A/P ratio in AD patients
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: Comparison of A/P ratio in VaD patients
Number of subjects: 74
Study: 10532588

Group type: EXPERIMENTAL
Intervention: Anti-CD59 immunocytochemistry
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Anti-MCP immunocytochemistry
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Anti-DAF immunocytochemistry
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: CR1 detection
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: In situ hybridization for CD59, MCP, DAF, and CR1 mRNA
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Reverse transcriptase-polymerase chain reaction
Number of subjects: 8
Study: 8558644

Group type: EXPERIMENTAL
Intervention: Adjuvant CMV chemotherapy (cisplatin, methotrexate, vinblastine)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Observation
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: CMV chemotherapy for salvage after relapse
Number of subjects: 50
Study: 1869388

Group type: EXPERIMENTAL
Intervention: Piperacillin (2 gr)
Number of subjects: 103

Group type: COMPARATOR
Intervention: Tobramycin (100 mg)
Number of subjects: 103
Study: 7041150

Group type: EXPERIMENTAL
Intervention: Early excision and grafting within 5 days after the burn
Number of subjects: 0

Group type: COMPARATOR
Intervention: Nonsurgical treatment with topical chemotherapy and hydrotherapy
Number of subjects: 0
Study: 31242190

Group type: EXPERIMENTAL
Intervention: Water treatment
Number of subjects: 9077

Group type: EXPERIMENTAL
Intervention: Improved sanitation
Number of subjects: 9077

Group type: EXPERIMENTAL
Intervention: Handwashing with soap
Number of subjects: 9077

Group type: EXPERIMENTAL
Intervention: Combined water treatment, sanitation, and handwashing (WSH)
Number of subjects: 9077

Group type: EXPERIMENTAL
Intervention: Improved nutrition
Number of subjects: 9077

Group type: EXPERIMENTAL
Intervention: Combined WSH and nutrition (WSHN)
Number of subjects: 9077

Group type: COMPARATOR
Intervention: Control group (received household visits but no interventions)
Number of subjects: 9077
Study: 28873118

Group type: EXPERIMENTAL
Intervention: Topical timolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study: 26233235

Group type: EXPERIMENTAL
Intervention: Personal Contact
Number of subjects: 103

Group type: COMPARATOR
Intervention: Self-Help
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 103
Study: 24480899

Group type: EXPERIMENTAL
Intervention: 7-day intensive cognitive therapy for PTSD
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 3 months of standard weekly cognitive therapy
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: 3 months of weekly emotion-focused supportive therapy
Number of subjects: 121

Group type: COMPARATOR
Intervention: 14-week waiting list condition
Number of subjects: 121
Study: 21842157

Group type: EXPERIMENTAL
Intervention: 0.42 mg/kg d,l‐methamphetamine
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 19679580

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Low-dose dexmedetomidine (loading 3 microg kg(‐1) h(‐1) for 10 min; maintenance 0.2 microg kg(‐1) h(‐1) for 60 min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Moderate-dose dexmedetomidine (loading 6 microg kg(‐1) h(‐1) for 10 min; maintenance 0.4 microg kg(‐1) h(‐1) for 60 min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (both doses)
Number of subjects: 12
Study: 17430414

Group type: EXPERIMENTAL
Intervention: Patients' daily ratings of mood and functional impairment
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Patients' daily ratings of mood
Number of subjects: 10
Study: 15601655

Group type: EXPERIMENTAL
Intervention: Amino acid-based elemental feed (AAF) for 4 weeks
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard nutritional rehabilitation (skimmed milk and then soya) for 4 weeks
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 200
Study: 12167446

Group type: EXPERIMENTAL
Intervention: Granisetron (3 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Granisetron (3 mg) plus dexamethasone (8 mg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Droperidol (1.25 mg)
Number of subjects: 60
Study: 10539742

Group type: COMPARATOR
Intervention: Sitostanol powder (1 g)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sitostanol in lecithin micelles (700 mg)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Sitostanol in lecithin micelles (300 mg)
Number of subjects: 6
Study: 8787461

Group type: EXPERIMENTAL
Intervention: Normothermic cardiopulmonary bypass (37 degrees C)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Hypothermic cardiopulmonary bypass (27 degrees C)
Number of subjects: 60
Study: 2112906

Group type: EXPERIMENTAL
Intervention: Hospital-based home care (n = 211)
Number of subjects: 419

Group type: COMPARATOR
Intervention: Customary care (n = 208)
Number of subjects: 419